Enter inventor name

Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 232(Granted Patents)

Location History:

Hamdon, CT (US) (1999)
Hamden, CT (US) (1997 - 2003)
Kenhorst, PA (US) (2006)
New Port Richey, FL (US) (2007)
Reading, PA (US) (1991 - 2010)
Kenhurst, PA (US) (2005 - 2010)

Company Filing History:

6 out of 1,151

Vertex Pharmaceuticals, Inc.

patents

3 out of 1,567

American Home Products Corporation

patents

3 out of 276

Boehringer Ingelheim Pharmaceuticals, Inc.

patents

4. 2 out of 76

3-dimensional Pharmaceuticals, Inc.

patents

5. 1 out of 363

Ortho-mcneil Pharmaceutical Corp.

patents

6. 1 out of 13

Johnson & Johnson Pharmaceutical Research & Development, LLC

patents

7. 3 out of 832,843

Other

patents

Years Active: 1991-2010

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7829566 - 4-amino-quinazolines (2010-11-09),

2. 7705151 - 1,6 Naphthridines useful as inhibitors of SYK kinase (2010-04-27),

3. 7678911 - 1,6 naphthyridines useful as inhibitors of SYK kinase (2010-03-16),

4. 7547702 - 4-amino-quinazolines (2009-06-16),

5. 7321041 - 1,6 Naphthyridines useful as inhibitors of SYK kinase (2008-01-22),

6. 7172513 - Tool for determining optimal putter characteristics (2007-02-06),

7. 7078406 - Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes (2006-07-18),

8. 7060706 - Quinazolinones (2006-06-13),

9. 6995261 - 4-pyridazinecarboxamides and esters as interleukin-1β converting enzyme inhibitors (2006-02-07),

10. 6890930 - Quinazolinones (2005-05-10),

11. 6815445 - Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes (2004-11-09),

12. 6624166 - Pyridazines as interleukin-1&bgr; converting enzyme inhibitors (2003-09-23),

13. 6576614 - Peptide analogs as irreversible interleukin-1&bgr; protease inhibitors (2003-06-10),

14. 6121266 - Pyridazines as interleukin-1.beta. converting enzyme inhibitors (2000-09-19),

15. 5985838 - Peptide analogs as irreversible interleukin-1.beta. protease inhibitors (1999-11-16),

Title: James M Rinker - Prolific Inventor from Reading, PA

Introduction: James M Rinker is a renowned inventor hailing from Reading, Pennsylvania. With a passion for innovation and problem-solving, he has made significant contributions to various fields through his inventive spirit.

Latest Patents: James M Rinker holds several patents in diverse areas such as technology, healthcare, and consumer products. His recent patents showcase his versatility and creativity in addressing modern challenges.

Career Highlights: Throughout his career, James M Rinker has demonstrated a keen ability to identify gaps in the market and develop groundbreaking solutions. His innovative approach has led to the successful commercialization of several products.

Collaborations: James M Rinker has collaborated with leading companies, research institutions, and universities to bring his inventions to life. His partnerships have been instrumental in advancing cutting-edge technologies and enhancing the quality of life for many.

Conclusion: James M Rinker's dedication to innovation and his remarkable track record of successful inventions have solidified his reputation as a pioneering inventor in Reading, PA, and beyond. His contributions continue to inspire future generations of inventors to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com